Stocks to Watch: Key India triggers for 10 June 2026
Ajanta Pharma Ltd
AJANTPHARM
Ask AI
Market setup for June 10
Indian equities are expected to see stock-specific action on Tuesday, June 10, as investors react to a set of corporate developments across pharma, telecom, aviation, infrastructure, and PSU disinvestment. The focus is on events with clear near-term implications such as block deals, offer-for-sale (OFS) timelines, a Bombay High Court ruling on spectrum charges, and a rise in aviation turbine fuel (ATF) prices. Several of the updates are transaction-led, which can influence near-term liquidity and positioning. Others, such as the fuel price regime for airlines and the fertiliser subsidy discussion, reflect broader policy-linked sensitivities.
Ajanta Pharma: block deal activity
Ajanta Pharma is on watch after promoter entity Ravi Agrawal Trust sold 34.5 lakh shares, representing a 2.8% stake, through a block deal worth around ₹1,024 crore. The transaction was executed at an average price of ₹2,968 per share. On the buy side, Kotak Mahindra Mutual Fund acquired 21 lakh shares worth ₹624 crore, while Aditya Birla Sun Life Mutual Fund purchased 13.5 lakh shares valued at ₹400 crore. With both the seller and buyers identified and the price disclosed, the market is likely to track how the block deal impacts near-term float and sentiment.
Ajanta Pharma: semaglutide marketing pact with Biocon
Ajanta Pharma also drew attention after it signed an agreement with Biocon to market semaglutide. Under the agreement, Biocon will supply semaglutide to Ajanta Pharma for exclusive marketing in 23 countries and semi-exclusive marketing in three countries across Africa, West Asia, and Central Asia. The information flow around the agreement has kept the stock in focus, alongside existing brokerage commentary cited in market reports. Investors typically track such licensing arrangements for execution visibility and how quickly commercial activity scales across the covered geographies.
Emcure Pharmaceuticals: another large block deal
Emcure Pharmaceuticals is in focus after BC Investments IV sold 36 lakh shares for around ₹612 crore through a block deal. Kotak Mahindra Mutual Fund bought these shares at an average price of ₹1,700 per share. Block deals of this size often draw attention because they can reset near-term supply and demand dynamics, especially when they involve well-known institutional participants.
Telecom: Bombay High Court ruling and relief for operators
Telecom stocks are being monitored following a Bombay High Court decision that set aside a one-time spectrum charge demand of ₹473.7 crore by the Department of Telecommunications on Bharti Hexacom. The petition was filed by the company through its promoter Bharti Airtel challenging a demand notice dated January 8, 2013 (revised in 2018), linked to its Rajasthan and North East circles.
Separately, Bharti Airtel and Vodafone Idea said the decision on one-time spectrum charges provides more than ₹10,500 crore of financial relief. The market will track how investors interpret the reduced overhang from potential liabilities, given the direct linkage between regulatory claims and balance-sheet risk in the sector.
IndiGo and SpiceJet: ATF prices rise and stabilisation scheme
Aviation counters such as IndiGo and SpiceJet are in focus after ATF prices were raised by around 10%. In Delhi, ATF increased from ₹104.93 to ₹115 per litre, which can raise operating costs for carriers.
Alongside the price hike, state-owned fuel retailers rolled out a price stabilisation regime that offers domestic airlines a fixed fuel rate for up to three years. The new rate will be locked in for up to three years for airlines that opt into the government-backed scheme. Traders are likely to watch for further clarity on participation and how airlines manage near-term cost volatility.
Afcons Infra: Vadhvan Port breakwater project
Afcons Infra has received a Letter of Award from Vadhvan Port Project Limited (VPPL) for constructing a 10.14 km-long breakwater at the upcoming Vadhvan Port in Maharashtra. The project award value is ₹5,301 crore. The company has said that once completed, it will be the second longest breakwater in the world. This is an engineering-heavy project, and the market typically tracks such awards for their potential impact on order books and execution timelines.
JSW Infrastructure: LoA for Kolkata Dock System terminal
JSW Infrastructure has received a Letter of Award from the Syama Prasad Mookerjee Port Authority (SMPA), Kolkata Port, after a competitive bidding process. The award is for the integrated development of the outer container terminal comprising two berths and five berths at Netaji Subhas Dock (NSD) in the Kolkata Dock System. Investors will likely track further disclosures for project scope, capex visibility, and time-to-revenue milestones.
FirstCry-linked Swara Baby Products: IPO plan
Brainbees Solutions (FirstCry) is in focus after reports said Swara Baby Products, backed by FirstCry, is planning to file draft papers with Sebi this month to raise up to ₹1,000 crore through an IPO. Swara Baby Products is described as a contract manufacturer of baby diapers, adult diapers, and feminine hygiene products. Any progress on filings, structure, and use of proceeds could influence how investors view the broader FirstCry ecosystem.
SBI and Sun Pharma: overseas acquisition funding
State Bank of India (SBI) plans to join a group of global lenders in funding Sun Pharmaceutical Industries’ $12 billion overseas acquisition, as reported by Bloomberg. SBI is set to commit as much as $1 billion. Funding news like this tends to be watched from both sides: for the lender’s exposure and for the borrower’s financing certainty around large transactions.
Fertiliser stocks: subsidy bill risk in focus
Fertiliser stocks such as Coromandel International, Chambal Fertilisers & Chemicals, Deepak Fertilisers, FACT, and RCF are in focus amid reports that a surge in global fertiliser prices linked to the West Asia war may double the Central government’s fertiliser subsidy bill. The Budget estimate for 2026-27 (FY27) was ₹1.7 trillion, and officials from the Department of Fertilisers have reportedly met Finance Minister Nirmala Sitharaman three times to seek a 100% increase in subsidy this year. Markets will track follow-through on policy actions and any implications for subsidy receivables and working capital.
NLC India: OFS details and expanded divestment size
NLC India remains a key focus area due to the government’s divestment plan via an offer for sale. The government exercised the oversubscription option in the ongoing OFS, increasing the stake sale size to 3% from the originally planned 2%. The total offer size now stands at 4.16 crore shares, representing 3% of the company’s paid-up equity capital as of March 31, 2026.
The OFS opens for retail investors on June 10, at a floor price of ₹303 per share. With a clear floor price and a defined stake size, investors are likely to track subscription trends and post-OFS price discovery.
Key numbers at a glance
Market impact: what investors will track during the session
The day’s flow is led by events with definable price points and share quantities, such as Ajanta Pharma and Emcure block deals and the NLC India OFS. These can affect near-term liquidity and institutional positioning.
Policy and regulatory developments are also central. The Bombay High Court ruling on spectrum charges has immediate relevance for telecom sentiment, while ATF pricing changes matter for airline cost structures. For fertiliser names, the market is likely to track subsidy-related signals closely because subsidy expectations influence cash-flow timing and working capital.
Conclusion
June 10 is set up for company-specific moves, driven by disclosed block deals, new project awards, and regulatory and policy-linked triggers. The NLC India OFS, the telecom court ruling, and ATF price changes are likely to be the most watched developments through the trading session, with investors tracking subscription data, further company disclosures, and any additional official updates.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q4 Earnings Tracker